| MRKR Stock Yearly Return 2022 Table | ||||||||||||||||||||||||||||||
MRKR average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare MRKR average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| MRKR Share Performance |
| MRKR Stock Yearly Return 2022 Chart | |||
Also see: • MRKR YTD return • MRKR average annual return 10 years | |||
| About Marker Therapeutics Inc |
| Marker Therapeutics is a clinical-stage immuno-oncology company focusing on the development of T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Co. is developing three product candidates as part of its multi tumor associated antigen-specific T cell program for: autologous treatment of lymphoma, and selected solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia (AML); and off-the-shelf products in various indications. Co.'s clinical development programs are: MT-401 for the treatment of post-transplant AML; MT-401-OTS for the treatment of AML; and MT-601 for the treatment of lymphoma. The MRKR stock yearly return is shown above.
The yearly return on the MRKR stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2022 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the MRKR annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| MRKR Current Stock Quote |
 Free MRKR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Marker Therapeutics (MRKR) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
MRNA Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!